General ICGM project information

General ICGM project information

Last updated: 2024-08-13 14:16

Project name

Implantable Continuous Glucose Monitoring under an agreement with limited clinical application

Project abbreviation

ICGM

Project code

HDBP0210

Primary organization that oversees implementation of project

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Partner organization participating in project

  • Not available

Organization that commissioned this project

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Organization providing monetary or material support

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Brief project description

A new data collection need to be set up for the temporary reimbursement of an implantablecontinuous glucose monitoring(ICGM)system. This data collection is requested by the RIZIV/INAMI.Based on clinical and scientific ground and with regard to the optimal treatment of all patients withdiabetes mellitus type 1, it seems delicate to grant a definitive reimbursement for an implantablecontinuous glucose monitoring system.

Previous studies that investigate the use of real-time continuous glucose monitoring systems inpatients with type 1 diabetes have shown improved glycemic control and lowered risk of acutediabetes-related hospitalizations. However the added therapeutic value of the use of this device infollowing patient groups is not yet clearly defined in a randomized controlled study:

Patients with diabetes mellitus type 1, who are minimal 18 years old with allergic contactdermatitis

Patients with diabetes mellitus type 1, who are minimal 18 years old who have difficulties toapply a transdermal sensor because of physical inability

Therefore a temporary reimbursement (beperkte klinische toepassing (BKT)/ Application CliniqueLimitée (ACL)) of this device for this type of patients was chosen.

The results of this study could be used by the Commission for the Reimbursement of Implants andInvasive Medical Devices (CRIDMI) as basisfor theregulation for reimbursement.

Regulatory framework of this project

Consult the regulatory framework information published on the fair.healthdata.be pages.